ASX:NSB +61 8 6268 2641 ir@neuroscientific.com Level 4, 216 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000 ASX Announcement 13 August 2026 Pre-IND Meeting with US FDA Scheduled Critical regulatory milestone for planned Phase 2 clinical trial in the United States for...